Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and... von Bonner, James A, Prof, Harari, Paul M, Prof, Giralt, Jordi, Prof, Cohen, Roger B, Prof, Jones, Christopher U, MD, Sur, Ranjan K, Prof, Raben, David, Prof, Baselga, Jose, Prof, Spencer, Sharon A, Prof, Zhu, Junming, PhD, Youssoufian, Hagop, MD, Rowinsky, Eric K, MD, Ang, K Kian, Prof

Volltext

Targeted Induction of Apoptosis in Cancer Management: The Emerging Role of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Activating Agents von ROWINSKY, Eric K

Volltext

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck von Bonner, James A, Harari, Paul M, Giralt, Jordi, Azarnia, Nozar, Shin, Dong M, Cohen, Roger B, Jones, Christopher U, Sur, Ranjan, Raben, David, Jassem, Jacek, Ove, Roger, Kies, Merrill S, Baselga, Jose, Youssoufian, Hagop, Amellal, Nadia, Rowinsky, Eric K, Ang, K. Kian

Volltext

Raf: A Strategic Target for Therapeutic Development Against Cancer von BEERAM, Muralidhar, PATNALK, Amita, ROWINSKY, Eric K

Volltext

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 von SPRATLIN, Jennifer L, COHEN, Roger B, MEROPOL, Neal J, LEWIS, Nancy L, CHIOREAN, E. Gabriela, FOX, Floyd, YOUSSOUFIAN, Hagop, ROWINSKY, Eric K, GAIL ECKHARDT, S, EADENS, Matthew, GORE, Lia, CAMIDGE, D. Ross, DIAB, Sami, LEONG, Stephen, O'BRYANT, Cindy, CHOW, Laura Q. M, SERKOVA, Natalie J

Volltext

The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors von Rowinsky, Eric K

Volltext

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors von MITA, Alain C, DENIS, Louis J, SEMIOND, Dorothée, BESENVAL, Michèle, TOLCHER, Anthony W, ROWINSKY, Eric K, DEBONO, Johann S, GOETZ, Andrew D, OCHOA, Leonel, FOROUZESH, Bahram, BEERAM, Muralidhar, PATNAIK, Amita, MOLPUS, Kathleen

Volltext

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer von PEREZ-SOLER, Roman, CHACHOUA, Abraham, HAMMOND, Lisa A, ROWINSKY, Eric K, HUBERMAN, Mark, KARP, Daniel, RIGAS, James, CLARK, Gary M, SANTABARBARA, Pedro, BONOMI, Philip

Volltext

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines von Lenz, Heinz-Josef, Van Cutsem, Eric, Khambata-Ford, Shirin, Mayer, Robert J, Gold, Philip, Stella, Philip, Mirtsching, Barry, Cohn, Allen L, Pippas, Andrew W, Azarnia, Nozar, Tsuchihashi, Zenta, Mauro, David J, Rowinsky, Eric K

Volltext

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent von Angelot-Delettre, Fanny, Roggy, Anne, Frankel, Arthur E, Lamarthee, Baptiste, Seilles, Estelle, Biichle, Sabeha, Royer, Bernard, Deconinck, Eric, Rowinsky, Eric K, Brooks, Christopher, Bardet, Valerie, Benet, Blandine, Bennani, Hind, Benseddik, Zehaira, Debliquis, Agathe, Lusina, Daniel, Roussel, Mikael, Solly, Françoise, Ticchioni, Michel, Saas, Philippe, Garnache-Ottou, Francine

Volltext

IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor von ROWINSKY, Eric K, YOUSSOUFIAN, Hagop, TONRA, James R, SOLOMON, Phillip, BURTRUM, Douglas, LUDWIG, Dale L

Volltext

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advance... von MITA, Monica M, MITA, Alain C, KNOWLES, Heather, RIVERA, Victor M, KREISBERG, Jeff, BEDROSIAN, Camille L, TOLCHER, Anthony W, CHU, Quincy S, ROWINSKY, Eric K, FETTERLY, Gerald J, GOLDSTON, Michelle, PATNAIK, Amita, MATHEWS, Lesley, RICART, Alejandro D, MAYS, Theresa

Volltext

Targeting the molecular target of rapamycin (mTOR) von Rowinsky, Eric K

Volltext

Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193) von SLEDGE, George W, NEUBERG, Donna, BERNARDO, Patricia, INGLE, James N, MARTINO, Silvana, ROWINSKY, Eric K, WOOD, William C

Volltext

A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer von HIDALGO, Manuel, BUCKNER, Jan C, ERLICHMAN, Charles, POLLACK, Marilyn S, BENI, Joseph P, DUKART, Gary, MARSHALL, Bonnie, SPEICHER, Lisa, MOORE, Laurence, ROWINSKY, Eric K

Volltext

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies von Goel, Sanjay, Mita, Alain C, Mita, Monica, Rowinsky, Eric K, Chu, Quincy S, Wong, Nancy, Desjardins, Christopher, Fang, Fang, Jansen, Mendel, Shuster, Dale E, Mani, Sridhar, Takimoto, Chris H

Volltext

Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab von CURRAN, Desmond, GIRALT, Jordi, COMTE, Sylvie, BANNER, James A, HARARI, Paul M, ANG, K. Kian, COHEN, Roger B, KIES, Merrill S, JASSEM, Jacek, BASELGA, José, ROWINSKY, Eric K, AMELLAL, Nadia

Volltext

Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the Obese von SPARREBOOM, Alex, WOLFF, Antonio C, MATHIJSSEN, Ron H. J, CHATELUT, Etienne, ROWINSKY, Eric K, VERWEIJ, Jaap, BAKER, Sharyn D

Volltext

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Tri... von RANSON, Malcolm, HAMMOND, Lisa A, FEYEREISLOVA, Andrea, SWAISLAND, Helen, ROWINSKY, Eric K, FERRY, David, KRIS, Mark, TULLO, Andrew, MURRAY, Philip I, MILLER, Vince, AVERBUCH, Steve, OCHS, Judy, MORRIS, Charles

Volltext

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies von HIDALGO, Manuel, SIU, Lillian L, FERRANTE, Karen, VON HOFF, Daniel D, SILBERMAN, Sandra, ROWINSKY, Eric K, NEMUNAITIS, John, RIZZO, Jinee, HAMMOND, Lisa A, TAKIMOTO, Chris, ECKHARDT, S. Gail, TOLCHER, Anthony, BRITTEN, Carolyn D, DENIS, Louis

Volltext